|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/26 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2858671 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13744818.9 |
| Date of filing the European patent application | 2013-06-11 | |
| (97) | Date of publication of the European application | 2015-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation | 2019-10-25 |
| (86) | Number | PCT/IB2013/054777 |
| Date | 2013-06-11 |
| (87) | Number | WO 2013/186700 |
| Date | 2013-12-19 |
| (30) | Number | Date | Country code |
| 201261658472 P | 2012-06-12 | US |
| (72) |
COSENZA, Marta, CH
STARK, Christoph, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnų kompozicija |
| ANTIBODY FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2025-05-19 | 13 | 289.00 EUR |
| 2026-06-11 |